神经类固醇作为治疗耐药抑郁症的新兴疗法:机制和临床潜力
Krutika Nagpurkar1, Pratik Ghive1, Mayur Kale2
1Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, India.
Neuroscience
|May 21, 2025
概括
神经类固醇提供了治疗耐药抑郁症 (TRD) 的新疗法,通过针对多个系统,与传统抗抑郁药不同. 它们对那些对当前疗法没有反应的患者提供了快速和持续的缓解的承诺.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 耐治疗性抑郁症 (TRD) 影响那些对标准抗抑郁药物治疗没有反应的人.
- 传统的治疗方法有局限性,需要新的治疗方法.
- 神经类固醇是一种有前途的替代品,因为它们的快速和多样化的作用机制.
研究的目的:
- 审查神经类固醇在治疗耐药性抑郁症 (TRD) 的治疗潜力.
- 讨论TRD中基于神经类固醇的疗法的作用机制,临床证据和未来方向.
主要方法:
- 对抑郁症中神经类固醇的临床前和临床研究的文献综述.
- 对神经递质系统 (GABA_A,NMDA) 和HPA轴的神经类固醇调节的分析.
- 检查临床试验数据和FDA对神经类固醇治疗的批准.
主要成果:
- 神经类固醇调节GABA_A和NMDA受体,增强抑制性传播,并促进突触可塑性.
- 它们调节HPA轴,减少压力神经毒性,恢复神经化学平衡.
- 临床前和临床研究表明,快速和持续的抗抑郁药物效应,与布雷克萨诺隆批准作为一个关键的例子.
结论:
- 神经类固醇对TRD具有显著的治疗潜力,提供了超越单胺假说的范式转变.
- 解决生物可用性和安全性等挑战对于临床优化至关重要.
- 基于神经类固醇的治疗可以为治疗耐药性抑郁症患者提供新的希望.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
Antidepressant Drugs: Overview
344
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
344
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
266
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
266
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
Depression: Overview
205
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
205
Drugs Affecting Neurotransmitter Release or Uptake
916
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
916


